Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,483 | -1,294 | -2,174 | -2,804 | -1,278 |
| Depreciation Amortization | 1 | N/A | 1 | N/A | N/A |
| Other Working Capital | -93 | -209 | 111 | 57 | 97 |
| Other Operating Activity | -512 | -650 | -1,113 | 1,317 | 300 |
| Operating Cash Flow | $-4,088 | $-2,152 | $-3,174 | $-1,430 | $-881 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9 | -2 | -22 | -9 | N/A |
| Net Acquisitions | 77 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $68 | $-2 | $-22 | $-9 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | 57,237 | 23,071 | 1,209 |
| Other Financing Activity | 0 | 0 | -1,307 | -1,307 | 0 |
| Financing Cash Flow | $N/A | $N/A | $55,929 | $21,764 | $1,209 |
| Exchange Rate Effect | -47 | -5 | -11 | -4 | -2 |
| Beginning Cash Position | 52,902 | 52,902 | 244 | 244 | 244 |
| End Cash Position | 47,896 | 50,226 | 52,967 | 20,565 | 569 |
| Net Cash Flow | $-5,006 | $-2,676 | $52,723 | $20,322 | $325 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,088 | -2,152 | -3,174 | -1,430 | -881 |
| Capital Expenditure | -9 | -2 | -22 | -9 | 0 |
| Free Cash Flow | -4,097 | -2,154 | -3,196 | -1,438 | -881 |